Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Rebuttal From Drs Maldonado and Kropski.

Maldonado F, Kropski JA.

Chest. 2019 May;155(5):897-898. doi: 10.1016/j.chest.2019.02.326. No abstract available.

PMID:
31060704
2.

POINT: Should Transbronchial Cryobiopsies Be Considered the Initial Biopsy of Choice in Patients With a Possible Interstitial Lung Disease? Yes.

Maldonado F, Kropski JA.

Chest. 2019 May;155(5):893-895. doi: 10.1016/j.chest.2019.02.331. No abstract available.

PMID:
31060702
3.

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):199-208. doi: 10.1164/rccm.201810-1891OC.

4.

Epithelial Injury and Dysfunction in the Pathogenesis of Idiopathic PulmonaryFibrosis.

Winters NI, Burman A, Kropski JA, Blackwell TS.

Am J Med Sci. 2019 May;357(5):374-378. doi: 10.1016/j.amjms.2019.01.010. Epub 2019 Jan 22. Review.

PMID:
31010463
5.

Survival implications of transbronchial cryobiopsy and other diagnostic modalities in idiopathic pulmonary fibrosis.

Pannu JK, Hewlett JC, Smith AB, Mason WR, Chen H, Rickman OB, Lentz RJ, Kropski JA, Maldonado F.

J Thorac Dis. 2019 Feb;11(2):E20-E23. doi: 10.21037/jtd.2019.01.44. No abstract available.

6.

Identifying Mesenchymal Pathways That Initiate Emphysema in Order to Develop Targeted Therapies.

Gaskill CF, Kropski JA, Richmond BW, Foronjy RF, Taketo MM, Majka SM.

Ann Am Thorac Soc. 2018 Dec;15(Supplement_4):S291-S292. doi: 10.1513/AnnalsATS.201804-229MG.

PMID:
30759014
7.

Progress in Understanding and Treating Idiopathic Pulmonary Fibrosis.

Kropski JA, Blackwell TS.

Annu Rev Med. 2019 Jan 27;70:211-224. doi: 10.1146/annurev-med-041317-102715.

PMID:
30691371
8.

Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.

Wu AC, Kiley JP, Noel PJ, Amur S, Burchard EG, Clancy JP, Galanter J, Inada M, Jones TK, Kropski JA, Loyd JE, Nogee LM, Raby BA, Rogers AJ, Schwartz DA, Sin DD, Spira A, Weiss ST, Young LR, Himes BE.

Am J Respir Crit Care Med. 2018 Dec 15;198(12):e116-e136. doi: 10.1164/rccm.201810-1895ST.

PMID:
30640517
9.

PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production.

Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, Chioma OS, Lee G, Hassell NE, Shaginurova GI, Wang Y, Johnson JE, Kerrigan A, Mason WR, Baughman RP, Ayers GD, Bernard GR, Culver DA, Montgomery CG, Maher TM, Molyneaux PL, Noth I, Mutsaers SE, Prele CM, Peebles RS Jr, Newcomb DC, Kaminski N, Blackwell TS, Van Kaer L, Drake WP.

Sci Transl Med. 2018 Sep 26;10(460). pii: eaar8356. doi: 10.1126/scitranslmed.aar8356.

10.

Localized hypoxia links ER stress to lung fibrosis through induction of C/EBP homologous protein.

Burman A, Kropski JA, Calvi CL, Serezani AP, Pascoalino BD, Han W, Sherrill T, Gleaves L, Lawson WE, Young LR, Blackwell TS, Tanjore H.

JCI Insight. 2018 Aug 23;3(16). pii: 99543. doi: 10.1172/jci.insight.99543. eCollection 2018 Aug 23.

11.

Interstitial Pneumonia With Autoimmune Features: An Emerging Challenge at the Intersection of Rheumatology and Pulmonology.

Wilfong EM, Lentz RJ, Guttentag A, Tolle JJ, Johnson JE, Kropski JA, Kendall PL, Blackwell TS, Crofford LJ.

Arthritis Rheumatol. 2018 Dec;70(12):1901-1913. doi: 10.1002/art.40679. Epub 2018 Oct 27. Review.

PMID:
30058242
12.

Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.

Dressen A, Abbas AR, Cabanski C, Reeder J, Ramalingam TR, Neighbors M, Bhangale TR, Brauer MJ, Hunkapiller J, Reeder J, Mukhyala K, Cuenco K, Tom J, Cowgill A, Vogel J, Forrest WF, Collard HR, Wolters PJ, Kropski JA, Lancaster LH, Blackwell TS, Arron JR, Yaspan BL.

Lancet Respir Med. 2018 Aug;6(8):603-614. doi: 10.1016/S2213-2600(18)30135-8. Epub 2018 Jun 18.

PMID:
29891356
13.

Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Hewlett JC, Kropski JA, Blackwell TS.

Matrix Biol. 2018 Oct;71-72:112-127. doi: 10.1016/j.matbio.2018.03.021. Epub 2018 Apr 3. Review.

PMID:
29625182
14.

Successful Establishment of Primary Type II Alveolar Epithelium with 3D Organotypic Coculture.

Sucre JMS, Jetter CS, Loomans H, Williams J, Plosa EJ, Benjamin JT, Young LR, Kropski JA, Calvi CL, Kook S, Wang P, Gleaves L, Eskaros A, Goetzl L, Blackwell TS, Guttentag SH, Zijlstra A.

Am J Respir Cell Mol Biol. 2018 Aug;59(2):158-166. doi: 10.1165/rcmb.2017-0442MA.

PMID:
29625013
15.

Three-dimensional spatial analysis of missense variants in RTEL1 identifies pathogenic variants in patients with Familial Interstitial Pneumonia.

Sivley RM, Sheehan JH, Kropski JA, Cogan J, Blackwell TS, Phillips JA, Bush WS, Meiler J, Capra JA.

BMC Bioinformatics. 2018 Jan 23;19(1):18. doi: 10.1186/s12859-018-2010-z.

16.

A Shared Pattern of β-Catenin Activation in Bronchopulmonary Dysplasia and Idiopathic Pulmonary Fibrosis.

Sucre JMS, Deutsch GH, Jetter CS, Ambalavanan N, Benjamin JT, Gleaves LA, Millis BA, Young LR, Blackwell TS, Kropski JA, Guttentag SH.

Am J Pathol. 2018 Apr;188(4):853-862. doi: 10.1016/j.ajpath.2017.12.004. Epub 2018 Jan 31.

17.

Endoplasmic reticulum stress in the pathogenesis of fibrotic disease.

Kropski JA, Blackwell TS.

J Clin Invest. 2018 Jan 2;128(1):64-73. doi: 10.1172/JCI93560. Epub 2018 Jan 2. Review.

18.

Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).

Kropski JA, Richmond BW, Gaskill CF, Foronjy RF, Majka SM.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217739807. doi: 10.1177/2045893217739807. Epub 2017 Oct 17.

19.

Utility of Flexible Bronchoscopic Cryobiopsy for Diagnosis of Diffuse Parenchymal Lung Diseases.

Lentz RJ, Taylor TM, Kropski JA, Sandler KL, Johnson JE, Blackwell TS, Maldonado F, Rickman OB.

J Bronchology Interv Pulmonol. 2018 Apr;25(2):88-96. doi: 10.1097/LBR.0000000000000401.

20.

Reply: The Genetic Diagnosis of Interstitial Lung Disease: A Need for an International Consensus.

Kropski JA, Young LR, Blackwell TS, Loyd JE.

Am J Respir Crit Care Med. 2017 Jun 1;195(11):1539-1540. doi: 10.1164/rccm.201612-2520LE. No abstract available.

21.

Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction.

Gaskill CF, Carrier EJ, Kropski JA, Bloodworth NC, Menon S, Foronjy RF, Taketo MM, Hong CC, Austin ED, West JD, Means AL, Loyd JE, Merryman WD, Hemnes AR, De Langhe S, Blackwell TS, Klemm DJ, Majka SM.

J Clin Invest. 2017 Jun 1;127(6):2262-2276. doi: 10.1172/JCI88629. Epub 2017 May 2.

22.

Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families.

Kropski JA, Reiss S, Markin C, Brown KK, Schwartz DA, Schwarz MI, Loyd JE, Phillips JA 3rd, Blackwell TS, Cogan JD.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1481-1484. doi: 10.1164/rccm.201703-0635LE. No abstract available.

23.

Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease.

Gaskill C, Marriott S, Pratap S, Menon S, Hedges LK, Fessel JP, Kropski JA, Ames D, Wheeler L, Loyd JE, Hemnes AR, Roop DR, Klemm DJ, Austin ED, Majka SM.

Pulm Circ. 2016 Dec;6(4):483-497. doi: 10.1086/688314.

24.

Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis.

Kropski JA, Young LR, Cogan JD, Mitchell DB, Lancaster LH, Worrell JA, Markin C, Liu N, Mason WR, Fingerlin TE, Schwartz DA, Lawson WE, Blackwell TS, Phillips JA 3rd, Loyd JE.

Am J Respir Crit Care Med. 2017 Jun 1;195(11):1423-1428. doi: 10.1164/rccm.201609-1820PP. No abstract available.

25.

Accumulation of isolevuglandin-modified protein in normal and fibrotic lung.

Mont S, Davies SS, Roberts Second LJ, Mernaugh RL, McDonald WH, Segal BH, Zackert W, Kropski JA, Blackwell TS, Sekhar KR, Galligan JJ, Massion PP, Marnett LJ, Travis EL, Freeman ML.

Sci Rep. 2016 Apr 27;6:24919. doi: 10.1038/srep24919.

26.

Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.

Hemnes AR, Zhao M, West J, Newman JH, Rich S, Archer SL, Robbins IM, Blackwell TS, Cogan J, Loyd JE, Zhao Z, Gaskill C, Jetter C, Kropski JA, Majka SM, Austin ED.

Am J Respir Crit Care Med. 2016 Aug 15;194(4):464-75. doi: 10.1164/rccm.201508-1678OC.

27.

A Phenome-Wide Association Study Identifies a Novel Asthma Risk Locus Near TERC.

Claar DD, Larkin EK, Bastarache L, Blackwell TS, Loyd JE, Hartert TV, Denny JC, Kropski JA.

Am J Respir Crit Care Med. 2016 Jan 1;193(1):98-100. doi: 10.1164/rccm.201507-1267LE. No abstract available.

28.

Personalizing Therapy in Idiopathic Pulmonary Fibrosis: A Glimpse of the Future?

Kropski JA, Lawson WE, Blackwell TS.

Am J Respir Crit Care Med. 2015 Dec 15;192(12):1409-11. doi: 10.1164/rccm.201509-1789ED. No abstract available.

29.

Telomeres revisited: RTEL1 variants in pulmonary fibrosis.

Kropski JA, Loyd JE.

Eur Respir J. 2015 Aug;46(2):312-4. doi: 10.1183/13993003.00710-2015. No abstract available.

30.

The genetic basis of idiopathic pulmonary fibrosis.

Kropski JA, Blackwell TS, Loyd JE.

Eur Respir J. 2015 Jun;45(6):1717-27. doi: 10.1183/09031936.00163814. Epub 2015 Apr 2.

31.

Rare variants in RTEL1 are associated with familial interstitial pneumonia.

Cogan JD, Kropski JA, Zhao M, Mitchell DB, Rives L, Markin C, Garnett ET, Montgomery KH, Mason WR, McKean DF, Powers J, Murphy E, Olson LM, Choi L, Cheng DS, Blue EM, Young LR, Lancaster LH, Steele MP, Brown KK, Schwarz MI, Fingerlin TE, Schwartz DA, Lawson WE, Loyd JE, Zhao Z, Phillips JA 3rd, Blackwell TS.

Am J Respir Crit Care Med. 2015 Mar 15;191(6):646-55. doi: 10.1164/rccm.201408-1510OC.

32.

Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.

Kropski JA, Pritchett JM, Zoz DF, Crossno PF, Markin C, Garnett ET, Degryse AL, Mitchell DB, Polosukhin VV, Rickman OB, Choi L, Cheng DS, McConaha ME, Jones BR, Gleaves LA, McMahon FB, Worrell JA, Solus JF, Ware LB, Lee JW, Massion PP, Zaynagetdinov R, White ES, Kurtis JD, Johnson JE, Groshong SD, Lancaster LH, Young LR, Steele MP, Phillips Iii JA, Cogan JD, Loyd JE, Lawson WE, Blackwell TS.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):417-26. doi: 10.1164/rccm.201406-1162OC.

33.

ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.

Marriott S, Baskir RS, Gaskill C, Menon S, Carrier EJ, Williams J, Talati M, Helm K, Alford CE, Kropski JA, Loyd J, Wheeler L, Johnson J, Austin E, Nozik-Grayck E, Meyrick B, West JD, Klemm DJ, Majka SM.

Am J Physiol Cell Physiol. 2014 Oct 15;307(8):C684-98. doi: 10.1152/ajpcell.00114.2014.

34.

Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.

West JD, Austin ED, Gaskill C, Marriott S, Baskir R, Bilousova G, Jean JC, Hemnes AR, Menon S, Bloodworth NC, Fessel JP, Kropski JA, Irwin D, Ware LB, Wheeler L, Hong CC, Meyrick B, Loyd JE, Bowman AB, Ess KC, Klemm DJ, Young PP, Merryman WD, Kotton D, Majka SM.

Am J Physiol Cell Physiol. 2014 Sep 1;307(5):C415-30. doi: 10.1152/ajpcell.00057.2014. Epub 2014 May 28.

35.

A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia.

Kropski JA, Mitchell DB, Markin C, Polosukhin VV, Choi L, Johnson JE, Lawson WE, Phillips JA 3rd, Cogan JD, Blackwell TS, Loyd JE.

Chest. 2014 Jul;146(1):e1-e7. doi: 10.1378/chest.13-2224.

36.

Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease.

Kropski JA, Pritchett JM, Mason WR, Sivarajan L, Gleaves LA, Johnson JE, Lancaster LH, Lawson WE, Blackwell TS, Steele MP, Loyd JE, Rickman OB.

PLoS One. 2013 Nov 12;8(11):e78674. doi: 10.1371/journal.pone.0078674. eCollection 2013.

37.

Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis.

Kropski JA, Lawson WE, Young LR, Blackwell TS.

Dis Model Mech. 2013 Jan;6(1):9-17. doi: 10.1242/dmm.010736. Review.

38.

The index case for the fungal meningitis outbreak in the United States.

Pettit AC, Kropski JA, Castilho JL, Schmitz JE, Rauch CA, Mobley BC, Wang XJ, Spires SS, Pugh ME.

N Engl J Med. 2012 Nov 29;367(22):2119-25. doi: 10.1056/NEJMoa1212292. Epub 2012 Oct 19.

39.

Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis.

Kropski JA, Lawson WE, Blackwell TS.

Am J Physiol Lung Cell Mol Physiol. 2012 Mar 1;302(5):L441-4. doi: 10.1152/ajplung.00335.2011. Epub 2011 Dec 16.

40.

Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome.

Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB.

Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1035-41. doi: 10.1152/ajplung.00214.2009. Epub 2009 Aug 21.

41.

Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.

Kropski JA, Fremont RD, Calfee CS, Ware LB.

Chest. 2009 Jun;135(6):1440-1447. doi: 10.1378/chest.08-2465. Epub 2009 Feb 2.

42.

School-based obesity prevention programs: an evidence-based review.

Kropski JA, Keckley PH, Jensen GL.

Obesity (Silver Spring). 2008 May;16(5):1009-18. doi: 10.1038/oby.2008.29. Epub 2008 Feb 28. Review.

Supplemental Content

Loading ...
Support Center